4 completed. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow afamelanotide: new trials by email Literature Review of afamelanotide trials Research Report on afamelanotide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients Afamelanotide 16mg implant - Erythropoietic Protoporphyria | Phase 1 / Phase 2 | Completed | Clinuvel Europe Limited | 28 | 2024-03-07 | 2026-07-27 |
| DNA Repair Capacity of Afamelanotide on Ultraviolet Radiation-induced DNA Damage in Healthy Volunteers Afamelanotide - Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers | Phase 1 | Completed | Clinuvel (UK) Ltd. | 10 | 2022-01-19 | 2023-02-09 |
| Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV) Afamelanotide, Narrow-Band UVB Light Treatment - Vitiligo | Phase 1 | Completed | Clinuvel Pharmaceuticals Limited | 56 | 2011-06-01 | 2013-03-22 |
| Implant Pharmacokinetic and Pharmacodynamic Study Afamelanotide Group 1, Afamelanotide Group 2 - Healthy | Phase 1 | Completed | Clinuvel Pharmaceuticals Limited | 24 | 2009-09-01 | 2018-08-16 |
Protoporphyria, Erythropoietic (1) · Vitiligo (1)
Clinuvel Pharmaceuticals Limited (2) · Clinuvel (UK) Ltd. (1) · Clinuvel Europe Limited (1)
United States (2) · Belgium (1) · Netherlands (1) · United Kingdom (1)
Henry Lim, MD (1) · Mark A Matson, MD (1)